[Prion diseases]

Area of Science:

• Neuroscience
• Pathology
• Infectious Diseases

Background:

• Prion diseases, or transmissible spongiform encephalopathies (TSEs), are fatal neurodegenerative conditions.
• The causative agent is an abnormally folded prion protein (PrP), derived from a normal cellular protein.
• TSEs manifest in sporadic, genetic, and iatrogenic forms, with variant Creutzfeldt-Jakob disease (vCJD) linked to bovine spongiform encephalopathy (BSE).

Purpose of the Study:

• To provide an overview of prion diseases, their causative agents, and classifications.
• To highlight the current therapeutic landscape and the lack of effective treatments.

Main Methods:

• Review of existing literature on prion diseases.
• Classification of different forms of TSEs.
• Summary of therapeutic trial outcomes since the early 2000s.

Main Results:

• Prion diseases are characterized by the misfolding of PrP proteins, leading to neurodegeneration.
• Sporadic CJD is the most prevalent form.
• No therapeutic interventions have proven effective to date.

Conclusions:

• Prion diseases represent a significant challenge in neurodegenerative disorder research.
• The development of effective treatments for TSEs is urgently needed.